LEXICON PHARMACEUTICALS, INC. — Director's Dealing 2024

May 13, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEXICON PHARMACEUTICALS, INC. (LXRX)
CIK: 0001062822
Period of Report: 2024-05-13

Reporting Person: Swain Judith L (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-05-13	Stock Option (Right to Buy)	$1.79	A	44906	Acquired	2034-05-13	Common Stock (44906)	Direct
2024-05-13	Restricted Stock Units	$0	A	36810	Acquired		Common Stock (36810)	Direct

Footnotes

F1: Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date.

F2: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date.

F3: Each restricted stock unit represents a contingent right to receive one share of common stock.